FNY Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,600
| Closed | -$20K | – | 788 |
|
2024
Q4 | $20K | Buy |
+1,600
| New | +$20K | 0.01% | 419 |
|
2021
Q4 | – | Sell |
-1,500
| Closed | -$31K | – | 604 |
|
2021
Q3 | $31K | Buy |
+1,500
| New | +$31K | 0.01% | 421 |
|
2021
Q1 | – | Sell |
-1,776
| Closed | -$35K | – | 830 |
|
2020
Q4 | $35K | Buy |
1,776
+1,770
| +29,500% | +$34.9K | 0.01% | 439 |
|
2020
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 505 |
|
2020
Q1 | – | Sell |
-4,203
| Closed | -$73K | – | 566 |
|
2019
Q4 | $73K | Buy |
+4,203
| New | +$73K | 0.02% | 403 |
|
2018
Q3 | – | Sell |
-675
| Closed | -$12K | – | 906 |
|
2018
Q2 | $12K | Buy |
+675
| New | +$12K | ﹤0.01% | 377 |
|